StocksFundsScreenerSectorsWatchlists
SHC

SHC - Sotera Health Co Stock Price, Fair Value and News

12.03USD+0.16 (+1.35%)Delayed as of 28 Mar 2024, 09:59 am ET

Market Summary

SHC
USD12.03+0.16
Delayedas of 28 Mar 2024, 09:59 am
1.35%

SHC Alerts

  • 4 major insider sales recently.
  • Big jump in Earnings (Y/Y)

SHC Stock Price

View Fullscreen

SHC RSI Chart

SHC Valuation

Market Cap

3.4B

Price/Earnings (Trailing)

65.35

Price/Sales (Trailing)

3.2

EV/EBITDA

14.83

Price/Free Cashflow

-9.26

SHC Price/Sales (Trailing)

SHC Profitability

Operating Margin

55.00%

EBT Margin

10.10%

Return on Equity

11.58%

Return on Assets

1.64%

Free Cashflow Yield

-10.8%

SHC Fundamentals

SHC Revenue

Revenue (TTM)

1.0B

Rev. Growth (Yr)

23.31%

Rev. Growth (Qtr)

17.88%

SHC Earnings

Earnings (TTM)

51.4M

Earnings Growth (Yr)

112.1%

Earnings Growth (Qtr)

383.17%

Breaking Down SHC Revenue

52 Week Range

11.8319.40
(Low)(High)

Last 7 days

-22.2%

Last 30 days

-32.0%

Last 90 days

-32.0%

Trailing 12 Months

-11.7%

How does SHC drawdown profile look like?

SHC Financial Health

Current Ratio

2.42

Debt/Equity

5.01

Debt/Cashflow

-0.07

SHC Investor Care

Shares Dilution (1Y)

0.18%

Diluted EPS (TTM)

0.18

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023987.5M976.2M990.6M1.0B
2022956.1M970.8M993.3M1.0B
2021842.1M880.9M907.1M931.5M
2020788.3M798.2M808.2M818.2M
2019000778.3M

Tracking the Latest Insider Buys and Sells of Sotera Health Co

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 04, 2024
rutz michael p
acquired
-
-
34,270
president of sterigenics
Mar 04, 2024
gtcr investment xi llc
sold
-158,283,000
14.3075
-11,062,900
-
Mar 04, 2024
petras michael b. jr.
sold
-14,362,900
14.3075
-1,003,870
chairman & ceo
Mar 04, 2024
klee ann r.
sold
-82,268
14.3075
-5,750
-
Mar 04, 2024
lyons jonathan m.
acquired
-
-
41,124
sr. vice president, cfo
Mar 04, 2024
warburg pincus & co.
sold
-237,424,000
14.3075
-16,594,400
-
Mar 04, 2024
petras michael b. jr.
acquired
-
-
274,160
chairman & ceo
Mar 04, 2024
rutz michael p
sold
-1,189,080
14.3075
-83,109
president of sterigenics
Mar 04, 2024
dimitrief alexander
acquired
-
-
51,405
svp, general counsel and sec.
Mar 02, 2024
petras michael b. jr.
sold (taxes)
-721,652
14.56
-49,564
chairman & ceo

1–10 of 50

Which funds bought or sold SHC recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Mar 22, 2024
PNC FINANCIAL SERVICES GROUP, INC.
reduced
-3.64
5,937
76,718
-%
Mar 11, 2024
VANGUARD GROUP INC
added
0.56
18,679,100
161,185,000
-%
Mar 01, 2024
GOLDMAN SACHS GROUP INC
added
92.23
2,975,900
5,536,270
-%
Mar 01, 2024
Pineridge Advisors LLC
new
-
22,646
22,646
0.01%
Feb 28, 2024
AMERICAN INTERNATIONAL GROUP, INC.
reduced
-4.12
164,591
2,261,510
0.01%
Feb 26, 2024
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
unchanged
-
64,000
571,000
-%
Feb 22, 2024
SIERRA SUMMIT ADVISORS LLC
new
-
193,691
193,691
0.06%
Feb 21, 2024
FINDELL CAPITAL MANAGEMENT LLC
new
-
8,425,000
8,425,000
5.30%
Feb 16, 2024
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO
added
2.81
94,731
696,731
-%
Feb 16, 2024
PRICE T ROWE ASSOCIATES INC /MD/
added
5.63
126,000
797,000
-%

1–10 of 47

Are Funds Buying or Selling SHC?

Are funds buying SHC calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own SHC
No. of Funds

Unveiling Sotera Health Co's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2022
warburg pincus & co.
62.1%
175,695,524
SC 13G/A
Feb 11, 2022
gtcr investment xi llc
62.1%
175,695,524
SC 13G/A

Recent SEC filings of Sotera Health Co

View All Filings
Date Filed Form Type Document
Mar 22, 2024
PRE 14A
PRE 14A
Mar 06, 2024
4
Insider Trading
Mar 06, 2024
4
Insider Trading
Mar 06, 2024
4
Insider Trading
Mar 06, 2024
4
Insider Trading
Mar 06, 2024
4
Insider Trading
Mar 06, 2024
4
Insider Trading
Mar 05, 2024
4
Insider Trading
Mar 05, 2024
4
Insider Trading
Mar 04, 2024
8-K
Current Report

What is the Fair Value of SHC?

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Cheap
or
Expensive?


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks

Peers (Alternatives to Sotera Health Co)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
184.1B
23.9B
1.92% 4.87%
38.82
7.71
-10.33% -33.23%
44.8B
3.7B
-4.47% 16.47%
53.05
12.25
8.72% 24.44%
43.2B
6.7B
9.35% 8.66%
34.96
6.42
-2.81% -6.58%
14.5B
9.3B
4.27% -4.49%
16.99
1.57
-6.38% -9.73%
13.8B
4.1B
11.27% 27.86%
29.14
3.35
3.86% -2.39%
12.4B
1.9B
4.38% 126.16%
43.86
6.58
29.17% 15.26%
12.1B
2.5B
1.85% -6.90%
-59.47
4.86
19.93% 67.26%
10.9B
1.1B
31.87% 65.38%
-25.12
10.09
31.99% 20.63%
MID-CAP
3.3B
918.7M
-13.78% -12.36%
284.21
3.64
45.66% 172.57%
2.2B
563.9M
-23.06% -38.26%
-4.56
3.88
25.45% 26.76%
SMALL-CAP
544.7M
280.3M
17.34% 2.80%
-2.86
1.94
-12.89% -148.37%
89.4M
31.2M
-3.36% -85.17%
-1.01
2.86
5.03% -1.81%
35.5M
9.2M
-24.43% -39.17%
-1.95
3.86
16.43% 46.89%
7.3M
9.0M
-21.88% -54.13%
-1.01
0.81
-53.31% 2.21%
183.8K
25.9M
-50.00% -94.83%
-0.01
0.01
-57.78% -93.11%

Sotera Health Co News

Latest updates
Defense World23 hours ago
TheStreet25 Mar 202408:02 pm
InvestorsObserver25 Mar 202404:57 pm

Sotera Health Co Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
Revenue17.9%310263255221252249267237241226252212217200213188-
Cost Of Revenue11.1%13011711610911011311610810710110897.0096.0093.0094.0092.00-
Gross Profit23.4%18014614011214213615012913412614411512110811997.00-
Operating Expenses8.8%76.0070.0076.0078.0082.0073.0079.0075.0068.0060.0065.0069.0068.0060.0057.0052.00-
  S&GA Expenses11.5%60.0054.0060.0062.0066.0057.0063.0060.0052.0044.0050.0052.0053.0046.0043.0037.00-
EBITDA Margin422.9%0.34*-0.11*-0.12*-0.12*-0.10*0.33*0.33*0.34*0.32*0.27*0.27*0.26*-----
Interest Expenses-68.0%23.0072.0043.0035.0011.0023.0026.0016.005.0017.0017.0020.0047.0051.0049.0064.00-
Income Taxes91.0%27.0014.0011.003.00-58.7817.0018.0015.0023.0014.0019.003.008.00-1.214.00-12.23-
Earnings Before Taxes13872.3%66.000.0034.005.00-37842.0048.0045.0059.0041.0062.0014.00-35.08-0.5811.00-14.22-
EBT Margin129.6%0.10*-0.34*-0.30*-0.29*-0.24*0.20*0.20*0.22*0.19*0.09*0.05*-0.01*-----
Net Income383.2%39.00-13.6624.003.00-31925.0030.0031.0036.0027.0043.0011.00-43.680.007.00-1.96-
Net Income Margin115.8%0.05*-0.31*-0.27*-0.26*-0.23*0.12*0.13*0.14*0.13*0.04*0.01*-0.03*-----
Free Cashflow575.1%48.00-10.17-389-11.1330.0029.0022.0014.0025.0065.0054.0035.00-----
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q4
Assets3.1%3,1303,0373,0753,4143,1182,8112,8402,8362,7902,7432,8512,7772,761
  Current Assets7.2%557520547924645421399372346337401328315
    Cash Equivalents21.0%296245263648395165141121107115156108102
  Inventory27.4%48.0038.0042.0047.0037.0037.0040.0046.0054.0037.0036.0033.0034.00
  Net PPE-100.0%-884--775704700669651624624612610
  Goodwill0.9%1,1111,1011,1101,1031,1021,0921,1161,1261,1201,1031,1141,1071,116
Liabilities1.0%2,6872,6592,6573,0532,7672,2042,2042,1942,2032,2172,3282,3112,307
  Current Liabilities15.0%231201200600792140142144161134149138141
  Long Term Debt0.0%2,2242,2232,2222,2221,7471,7471,7461,7451,7441,7431,8381,8381,825
    LT Debt, Current-8.4%5.005.005.004.00197--------
    LT Debt, Non Current0.0%2,2242,2232,2222,2221,747--1,7451,744--1,8381,825
Shareholder's Equity17.6%444377418361350607636642586526523466455
  Retained Earnings5.6%-654-693-679-702-705-386-411-441-472-508-535-578-589
  Additional Paid-In Capital0.4%1,2151,2101,2031,1951,1901,1871,1821,1771,1731,1711,1681,1701,166
Shares Outstanding0.0%281281281281280280280280279279279279-
Minority Interest------------2.002.00
Float---1,871---1,948---2,403--
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
Cashflow From Operations170.3%113,12341,849-336,57533,871101,92667,77958,28949,96766,35180,93878,09756,15921,84546,05346,9975,690-
  Share Based Compensation-2.1%8,2048,3788,3737,2886,2564,6165,8014,5383,3813,5473,4933,4496,9689011,3931,725-
Cashflow From Investing-24.7%-64,826-51,978-53,134-44,968-71,738-38,966-35,709-35,483-72,263-16,596-24,455-46,519-18,774-116,482-10,449-12,989-
Cashflow From Financing-9.8%-3,793-3,454-710273,916199,244-400-634-449-1,782-103,414-8,307-3,783-10,52990,479-55,82549,307-

SHC Income Statement

2023-12-31
Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenues:   
Total net revenues$ 1,049,288$ 1,003,687$ 931,478
Cost of revenues:   
Total cost of revenues472,130446,683412,806
Gross profit577,158557,004518,672
Operating expenses:   
Selling, general and administrative expenses236,667245,714198,158
Amortization of intangible assets63,79962,94063,781
Total operating expenses300,466308,654261,939
Operating income276,692248,350256,733
Interest expense, net142,87880,14474,192
Impairment of investment in unconsolidated affiliate09,6130
Loss on extinguishment of debt0020,681
Foreign exchange loss1591451,345
Other income, net(7,372)(6,441)(15,201)
Income (loss) before income taxes106,027(243,111)175,716
Provision (benefit) for income taxes54,651(9,541)58,595
Net income (loss)51,376(233,570)117,121
Less: Net income attributable to noncontrolling interests00239
Net income (loss) attributable to Sotera Health Company51,376(233,570)116,882
Other comprehensive income (loss) net of tax:   
Pension and post-retirement benefits (net of taxes of $(3,420), $7,022 and $8,924, respectively)(10,506)20,79026,562
Interest rate derivatives (net of taxes of $(5,467), $7,387 and $142, respectively)(15,697)20,939404
Foreign currency translation40,174(64,816)(16,395)
Comprehensive income (loss)65,347(256,657)127,692
Less: comprehensive income attributable to noncontrolling interests00534
Comprehensive income (loss) attributable to Sotera Health Company$ 65,347$ (256,657)$ 127,158
Earnings (Loss) per share:   
Basic (in dollars per share)$ 0.18$ (0.83)$ 0.41
Diluted (in dollars per share)$ 0.18$ (0.83)$ 0.41
Weighted average number of shares outstanding:   
Basic (in shares)281,008280,096279,228
Diluted (in shares)283,222280,096279,382
Georgia EO litigation settlement   
Operating expenses:   
Litigation settlement$ 35,000$ 0$ 0
Illinois EO litigation settlement   
Operating expenses:   
Litigation settlement0408,0000
Service   
Revenues:   
Total net revenues905,598864,828805,501
Cost of revenues:   
Total cost of revenues418,611390,860357,205
Product   
Revenues:   
Total net revenues143,690138,859125,977
Cost of revenues:   
Total cost of revenues$ 53,519$ 55,823$ 55,601

SHC Balance Sheet

2023-12-31
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 296,407$ 395,214
Restricted cash short-term5,2471,080
Accounts receivable, net of allowance for uncollectible accounts of $4,689 and $1,871 as of December 31, 2023 and 2022, respectively147,696118,482
Inventories, net48,31637,145
Prepaid expenses and other current assets53,84680,995
Income taxes receivable5,73212,094
Total current assets557,244645,010
Property, plant, and equipment, net946,914774,527
Operating lease assets24,03726,481
Deferred income taxes4,9934,101
Post-retirement assets28,48235,570
Other assets41,24238,983
Other intangible assets, net416,318491,265
Goodwill1,111,1901,101,768
Total assets3,130,4203,117,705
Current liabilities:  
Accounts payable71,03974,139
Accrued liabilities122,471490,130
Deferred revenue13,49212,140
Current portion of long-term debt4,797197,119
Current portion of finance lease obligations8,7711,722
Current portion of operating lease obligations5,9347,554
Current portion of asset retirement obligations02,896
Income taxes payable4,1505,867
Total current liabilities230,654791,567
Long-term debt2,223,6741,747,115
Finance lease obligations, less current portion63,79356,955
Operating lease obligations, less current portion20,08721,577
Noncurrent asset retirement obligations47,94442,586
Deferred lease income18,76218,902
Post-retirement obligations8,4397,910
Noncurrent liabilities8,87912,831
Deferred income taxes64,45468,024
Total liabilities2,686,6862,767,467
See Commitments and contingencies note
Equity:  
Common stock, with $0.01 par value, 1,200,000 shares authorized; 286,037 shares issued at December 31, 2023 and 20222,8602,860
Preferred stock, with $0.01 par value, 120,000 shares authorized; no shares issued at December 31, 2023 and 202200
Treasury stock, at cost (3,207 and 3,616 shares at December 31, 2023 and 2022, respectively)(27,182)(29,775)
Additional paid-in capital1,215,1781,189,622
Retained deficit(654,440)(705,816)
Accumulated other comprehensive loss(92,682)(106,653)
Total equity443,734350,238
Total liabilities and equity$ 3,130,420$ 3,117,705
SHC
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing. It also provides microbiological and analytical chemistry testing, and advisory services. The company serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.
 CEO
 WEBSITEsoterahealth.com
 EMPLOYEES3000

Sotera Health Co Frequently Asked Questions


What is the ticker symbol for Sotera Health Co? What does SHC stand for in stocks?

SHC is the stock ticker symbol of Sotera Health Co. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Sotera Health Co (SHC)?

As of Wed Mar 27 2024, market cap of Sotera Health Co is 3.36 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SHC stock?

You can check SHC's fair value in chart for subscribers.

What is the fair value of SHC stock?

You can check SHC's fair value in chart for subscribers. The fair value of Sotera Health Co is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Sotera Health Co is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for SHC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Sotera Health Co a good stock to buy?

The fair value guage provides a quick view whether SHC is over valued or under valued. Whether Sotera Health Co is cheap or expensive depends on the assumptions which impact Sotera Health Co's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SHC.

What is Sotera Health Co's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Mar 27 2024, SHC's PE ratio (Price to Earnings) is 65.35 and Price to Sales (PS) ratio is 3.2. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SHC PE ratio will change depending on the future growth rate expectations of investors.